Skip to main content

Cell-Based Antiviral Assays for Screening and Profiling Inhibitors Against Dengue Virus

  • Protocol
  • First Online:
Antiviral Methods and Protocols

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1030))

Abstract

Dengue, a mosquito-borne virus of the Flaviviridae family, is reemerging as one of the most important human pathogens in tropical and subtropical regions of the world. It is estimated that 2.5 billion people live in areas at risk for transmission of dengue virus (DENV). Furthermore, it causes significant morbidity and mortality with 50–100 million infections per year. Currently, there are no vaccines commercially available and no effective antiviral drugs for treatment of DENV infections. In this chapter, we describe a plaque reduction assay and a cell-based high-throughput antiviral assay for identifying inhibitors against DENV. The latter is a homogeneous high-throughput assay that has been fully validated according to the Food and Drug Administration (FDA) guidelines for assay validation and can be used for screening compound libraries.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Halstead S (2007) Dengue. Lancet 370: 1644–1652

    Article  PubMed  Google Scholar 

  2. Whitehead S, Blaney J, Durbin A, Murphy B (2007) Prospects for a dengue virus vaccine. Nat Rev Microbiol 5:518–528

    Article  PubMed  CAS  Google Scholar 

  3. Gubler D, Kuno G, Markoff L (2007) Flaviviruses. In: Knipe D, Howley P et al (eds) Fields Virology, 5th edn. Lippincott Williams and Wilkins, New York, pp 1153–1252

    Google Scholar 

  4. Gong E, Ivens T, Clynhens M, Lory P, Kraus G (2010) A high throughput method for identifying inhibitors against dengue viruses. International Publication Number: WO2010/130748 A1

    Google Scholar 

  5. Gong E, Ivens T, Van den Eynde C et al (2008) Development of robust antiviral assays for profiling compounds against a panel of positive-strand RNA viruses using ATP/luminescence readout. J Virol Methods 151:121–125

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Gong, E.Y., Clynhens, M., Ivens, T., Lory, P., Simmen, K., Kraus, G. (2013). Cell-Based Antiviral Assays for Screening and Profiling Inhibitors Against Dengue Virus. In: Gong, E. (eds) Antiviral Methods and Protocols. Methods in Molecular Biology, vol 1030. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-484-5_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-484-5_15

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-483-8

  • Online ISBN: 978-1-62703-484-5

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics